Medibios Laboratories Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Medibios Labs.

DeciZen not available for IPO

10 Year X-Ray of Medibios Labs.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18TTM
ROCE %
15.6%19.9%24.7%28.6%38.1%26.4%-
Value Creation
Index
0.10.40.81.01.70.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales
32.935.937.240.149.459.760
Sales YoY Gr.
-9.1%3.5%7.8%23.4%20.7%-
Adj EPS
1.31.93.44.87.87.87.8
YoY Gr.
-42.1%81%39.8%63.4%0.4%-
BVPS (₹)
11.313.216.520.828.737.737.7
Adj Net
Profit
0.91.32.43.45.65.60
Cash Flow from Ops.
4.532.65.34.93.1-
Debt/CF from Ops.
1.92.53.41.71.53.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA12.6%17.1%20.7%
Adj EPS NA42.6%31.9%0.4%
BVPSNA27.1%31.8%31.3%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18TTM
Return on
Equity %
11.715.423.125.731.623.620.8
Op. Profit
Mgn %
1111.915.421.623.217.7NAN
Net Profit
Mgn %
2.93.76.58.511.29.30
Debt to
Equity
1.10.80.80.60.40.4-
Working Cap
Days
01311511431241540
Cash Conv.
Cycle
034504928600

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - Medibios Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 7.8 -
TTM Sales (₹ Cr.) 59.7 -
BVPS (₹.) 37.7 -
Reserves (₹ Cr.) 20 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) 10
Industry PE 37.5

Quarterly Results

 Mar'24 YoY Gr. Rt. %Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %
Sales (₹ Cr.) 2,413 -0.62,270 0.32,455 5.22,404 5
Adj EPS (₹) 6.5 247.9 72.57.6 71.27 26.4
Op. Profit Mgn % 12.56 193 bps15.17 554 bps12.84 427 bps12.90 253 bps
Net Profit Mgn % 7.73 154 bps9.99 418 bps8.95 345 bps8.47 143 bps

Management X-Ray of Medibios Labs.:

Shareholding Pattern

JavaScript chart by amCharts 3.21.5
JavaScript chart by amCharts 3.21.5Promoters:99.7%Institutions:0%Non-Institutions:0.3%

Promoter's Holding & Share Pledging

JavaScript chart by amCharts 3.21.5Sep170%20%40%60%80%100%120%
Pledged *0.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Medibios Labs.

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Medibios Labs.

Adj EPS (Rs.)

Price Chart, Live Stock Chart, Technical Chart of

Sales (Cr.)

Price Chart, Live Stock Chart, Technical Chart of

ROE (%)

Price Chart, Live Stock Chart, Technical Chart of

ROCE (%)

Price Chart, Live Stock Chart, Technical Chart of
Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Alembic Pharma 802.8 -10.6 (-1.3%) Small Cap 6,229 30.8 9.6 26.4 3.2
Laurus Labs 521.1 -15.4 (-2.9%) Small Cap 5,041 3.7 3.1 144.5 6.9
Piramal Pharma 208.6 -9.5 (-4.3%) Small Cap 4,390 5.2 8.4 42.1 4.1
Ajanta Pharma 2,607.3 -63.1 (-2.4%) Small Cap 4,209 71.9 19 37.2 8.5
Gland Pharma 1,524.3 3.9 (0.3%) Small Cap 4,167 68.1 24.8 22.3 2.7
Natco Pharma 797.8 4.8 (0.6%) Small Cap 3,999 104.1 34.5 7.6 2
Granules India 509 -18.4 (-3.5%) Small Cap 3,755 13.3 11.7 39.7 3.9
Emcure Pharma 996.8 5.2 (0.5%) Small Cap 3,498 8.5 4.4 116.8 6.5
JB Chem & Pharma 1,605.5 -25 (-1.5%) Small Cap 3,299 40.4 16.1 40.4 7.7
Sanofi India 5,076.8 -91.3 (-1.8%) Small Cap 2,851 184.4 20.8 28 15.5
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Sales32.8935.8837.1540.0649.4259.65
Operating Expenses 29.2731.6231.4131.683849.10
Manufacturing Costs8.248.968.8710.153.140
Material Costs17.281716.101421.2433.50
Employee Cost 2.362.793.6544.855.54
Other Costs 1.382.872.803.548.7710.06
Operating Profit 3.614.255.738.3811.4210.56
Operating Profit Margin (%) 11.0%11.9%15.4%20.9%23.1%17.7%
Other Income 0.190.340.080.020.030.30
Interest 1.201.351.011.401.410.83
Depreciation 1.191.241.172.051.682.30
Exceptional Items 000000
Profit Before Tax 1.4123.634.968.377.73
Tax 0.470.661.201.762.852.16
Profit After Tax 0.941.342.433.215.525.57
PAT Margin (%) 2.9%3.7%6.5%8.0%11.2%9.3%
Adjusted EPS (₹)1.31.93.44.57.87.8
Dividend Payout Ratio (%)4%3%2%2%1%1%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17Mar'18

Equity and Liabilities

Shareholders Fund 8.069.3411.7014.7620.3926.76
Share Capital 2.372.377.107.107.107.10
Reserves 5.696.974.597.6613.2919.66
Minority Interest000000
Debt7.856.688.397.787.1110.45
Long Term Debt1.120.021.494.613.224.24
Short Term Debt6.736.666.903.173.886.21
Trade Payables5.506.887.224.747.798.67
Others Liabilities 8.467.999.637.147.106.51
Total Liabilities 29.8630.8936.9334.4242.3952.40

Fixed Assets

Gross Block23.1824.3726.7728.733234.94
Accumulated Depreciation7.478.479.5110.4312.1614.28
Net Fixed Assets15.7215.9017.2618.3019.8420.66
CWIP 000000
Investments 001.241.241.241.27
Inventories5.264.615.633.586.4411.61
Trade Receivables5.097.3910.138.0111.4614.63
Cash Equivalents 0.990.570.260.140.220.02
Others Assets2.812.422.413.143.194.20
Total Assets 29.8630.8936.9334.4242.3952.40

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Cash Flow From Operating Activity 4.5032.625.304.893.05
PBT 1.4123.635.038.377.73
Adjustment 2.302.252.103.701.602.08
Changes in Working Capital 1.21-0.65-1.96-1.48-5.07-6.76
Tax Paid -0.42-0.60-1.16-1.8800
Cash Flow From Investing Activity -2.05-0.87-3.57-3.35-3.07-3.64
Capex -2.13-1.19-2.40-3.08-3.09-2.94
Net Investments 00-1.24000
Others 0.080.330.07-0.270.02-0.70
Cash Flow From Financing Activity -1.95-2.560.64-2.07-1.740.39
Net Proceeds from Shares 004.74000
Net Proceeds from Borrowing -0.36-1.091.473.1200
Interest Paid -1.20-1.35-1.01-1.4000
Dividend Paid -0.04-0.04-0.06-0.06-0.08-0.08
Others -0.34-0.07-4.49-3.73-1.650.47
Net Cash Flow 0.50-0.42-0.31-0.120.08-0.20
PARTICULARSMar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Ratios
ROE (%)11.7115.423.124.2331.3923.63
ROCE (%)15.5619.9224.7428.5638.0926.44
Asset Turnover Ratio1.151.261.161.181.371.29
PAT to CFO Conversion(x)4.792.241.081.650.890.55
Working Capital Days
Receivable Days545981796778
Inventory Days564747403554
Payable Days11613316015610890

Medibios Laboratories Ltd Stock News

No data found.

Medibios Laboratories Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Medibios Labs. on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Medibios Labs. stood at ₹0.00.
The latest P/E ratio of Medibios Labs. as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Medibios Labs. as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Medibios Labs. is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Medibios Labs. is ₹59.65 ( Cr.) .

About Medibios Laboratories Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on